Hi FeMike:
First, thank you for your comments. The points you make may well be valid.
However, my point was that I don’t agree with your statement that LP does not know what she is doing which is tantamount to calling her incompetent.
I don’t think any of us on this MB can conclude this. We do not sit where she does. We don’t have the facts she has. We don’t have her experience. We very likely don’t have her brain power. We certainly don’t have the phalanx of advisors she has. We don’t work at NWBO every day. We don’t have her resources. We don’t have the opportunity for collaborative decision making that she has. Accordingly, I think it quite unlikely that she is incompetent.
While I don’t like the deafening silence, missed guidelines, etc., this does not mean that well considered reasoning is lacking. Perhaps if I knew what she knows with benefit of her team of advisors, I would have made the same decisions. Who knows.
I don’t claim that she has not made mistakes. However, on the major strategic issues and decisions, these are assuredly well thought out and vetted with her counselors. In hindsight these decisions may not have been correct or even the best way to move forward, but they were well considered at the time and not incompetent decisions. To be sure not all company issues and operations involve such elaborate collaboration. Timeline guidance may have been one of them. I think that management wanted to throw shareholders a bone. I think counsel probably told them, OK, in the interest of investor relations but with all the caveats. However, continuing to miss the mark, probably they all came to the conclusion that due to external factors not under their control which significantly impacted their prognostications, they opted for silence and “don’t explain other than we are in a quiet period.”
LP has brought the company to where it is today on the brink of announcing what I think will be remarkable data and a new paradigm for SOC wrt the king of cancers. And she has done so in the face of daunting challenges where lesser resolute leaders may have given up. Has she made mistakes? Maybe. But incompetent? That is much too extreme a judgement. To repeat, we don’t sit where she does. Accordingly, the least we can say is to withhold judgement as, if and when she brings the company across the goal line. From what I see, overall, I give her the benefit of any doubt and firmly believe that her overall management will lead to success for patients and investors.
GLTU whatever you decide.
AI
